Sascha Bender

Summary

Affiliation: University of Wuerzburg
Country: Germany

Publications

  1. pmc Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases
    Christian Schem
    Department of Gynecology, University Hospital Schleswig Holstein, Campus Kiel, Germany
    BMC Cancer 13:32. 2013

Detail Information

Publications1

  1. pmc Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases
    Christian Schem
    Department of Gynecology, University Hospital Schleswig Holstein, Campus Kiel, Germany
    BMC Cancer 13:32. 2013
    ..In this preclinical study we examined whether sunitinib, a multi-tyrosine kinase inhibitor which has anti-angiogenic and anti-resorptive activity, is effective in the prevention of bone metastases...